Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation

Xu, HC; Jeught, KV; Zhou, ZL; Zhang, L; Yu, T; Sun, YF; Li, YJ; Wan, CL; So, KM; Liu, DG; Frieden, M; Fang, YZ; Mosley, AL; He, XM; Zhang, XN; Sandusky, GE; Liu, YL; Meroueh, SO; Zhang, C; Wijeratne, AB; Huang, C; Ji, G; Lu, XB

Huang, C (corresponding author), 1200 Cailun Rd, Shanghai 201203, Peoples R China.; Ji, G (corresponding author), 725 Wanping South Rd, Shanghai 200032, Peoples R China.; Lu, XB (corresponding author), 980 W Walnut St,R3-C218D, Indianapolis, IN 46202 USA.

JOURNAL OF CLINICAL INVESTIGATION, 2021; 131 (10):